SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-243285
Filing Date
2022-09-13
Accepted
2022-09-13 07:30:32
Documents
14
Period of Report
2022-09-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d388436d8k.htm   iXBRL 8-K 27727
2 EX-3.1 d388436dex31.htm EX-3.1 5579
3 EX-3.2 d388436dex32.htm EX-3.2 108160
  Complete submission text file 0001193125-22-243285.txt   307146

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ivvd-20220909.xsd EX-101.SCH 2884
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ivvd-20220909_lab.xml EX-101.LAB 20394
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ivvd-20220909_pre.xml EX-101.PRE 12678
8 EXTRACTED XBRL INSTANCE DOCUMENT d388436d8k_htm.xml XML 3914
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 221239737
SIC: 2836 Biological Products, (No Diagnostic Substances)